# SOLESENCE, INC. (SLSN) · Edgar & Edgarette company card

> Solesence (SLSN) grew revenue 18.6% in FY2025 to $62 million, operating margin 4.2% against a 3.3% median for perfumes, cosmetics & other toilet preparations, equity 30.2% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 883107 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SLSN) · [JSON](https://www.pops4.com/boards/company/SLSN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $62M |
| Revenue growth, 1 year | 18.6% |
| Revenue growth per year | 20.5% |
| Operating margin | 4.2% (prior year 3.8%) |
| Net margin | 4.5% |
| Operating cash flow | −$9M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $1M |
| Long-term debt | — |
| Total assets | $46M |
| Total equity | $14M |
| Equity ÷ assets | 30.2% |
| Return on equity | 20.1% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -4.77 (distress zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -0.97 (above the −1.78 line)
- Health Harbor boat: Old boat · three warning signs · filed earlier statements no longer to be relied on, late quarterly report notice in the last 12 months; operating cash flow was negative; revenue is hard to predict: its 80% range is ±37%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $62.1M (FY2025). Experience: revenue up 18.6% on the year, up 20.5% a year over 4 years; operating margin 4.2%, up from 3.8%. Soundness: equity 30.2% of assets, return on equity 20.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $48.1M and $105.1M next year (method v4.1: its own 6-year record of growth weighed at 63% against $50M–100M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $49.5M to $102.3M. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, perfumes, cosmetics & other toilet preparations): operating margin 4.2% against a 3.3% median; growth 18.6% against 0.1%.

Range logged 2026-10-06, receipt 15ad2925bdfb5ed0, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-10-02 ([filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326006367/0001171843-26-006367-index.htm))
- Item 4.02 Earlier statements no longer to be relied on: 1, latest 2026-08-21 ([filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326005702/0001171843-26-005702-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326005544/0001171843-26-005544-index.htm))
- Item 5.02 Director or officer change: 3, latest 2026-04-29 ([filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326002802/0001171843-26-002802-index.htm))

## Recent filings

- DEF 14A · filed 2026-11-16 · [filing](https://www.sec.gov/Archives/edgar/data/883107/000199937126025533/0001999371-26-025533-index.htm)
- 10-Q · filed 2026-11-12 · [filing](https://www.sec.gov/Archives/edgar/data/883107/000199937126025220/0001999371-26-025220-index.htm)
- 8-K · filed 2026-11-12 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326007397/0001171843-26-007397-index.htm)
- 8-K · filed 2026-10-05 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326006412/0001171843-26-006412-index.htm)
- 8-K · filed 2026-10-02 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326006367/0001171843-26-006367-index.htm)
- 8-K · filed 2026-08-21 · 4.02 Non-Reliance on Previously Issued Financial Statements; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/883107/000117184326005702/0001171843-26-005702-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000883107.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=883107

## Cite

POPS4, Edgar & Edgarette: SOLESENCE, INC. (SLSN) company card, from the company's own SEC filings, accessed 2026-11-20, https://www.pops4.com/boards/company/SLSN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

